Cipla Viraday Tablets

Description

Cipla Viraday Tablets are a fixed‑dose combination antiretroviral medicine containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate, used to treat HIV‑1 infection in adults. They work together to prevent the HIV virus from multiplying, helping to reduce the viral load and strengthen the immune system. Viraday is taken once daily by mouth, usually on an empty stomach, as prescribed by a healthcare provider. It helps manage HIV and delay progression to AIDS but does not cure the infection. Use must be under medical supervision due to possible side effects and the need for monitoring.